Correction: Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma

被引:0
|
作者
Astrid Lièvre
Bérèngere Ouine
Jim Canet
Aurélie Cartier
Yael Amar
Wulfran Cacheux
Odette Mariani
Rosine Guimbaud
Janick Selves
Thierry Lecomte
Serge Guyetant
Ivan Bieche
Frédérique Berger
Leanne de Koning
机构
[1] CHU Pontchaillou,Service des maladies de l’appareil digestif
[2] Université Rennes 1,Faculté de médecine
[3] Rue Bataille Flandres-Dunkerque,Inserm ER440
[4] Institut Curie,Oncogenesis, Stress and Signaling
[5] PSL Research University,Department of Translational Research
[6] PSL Research University,Institut Curie
[7] Unit of Biostatistics,Department of Medical Oncology, Institut Curie
[8] René Huguenin Hospital,Department of Genetics, Institut Curie
[9] Unit of Pharmacogenomics,Biological Resource Center, Institut Curie
[10] PSL Research University,Centre de Recherche en Cancérologie de Toulouse, Unité Mixte de Recherche
[11] 26 rue d’Ulm,Service d’oncologie médicale
[12] 1037 INSERM—Université Toulouse III,Department of Pathology
[13] Centre Hospitalier Universitaire de Toulouse,Hôpital Trousseau—CHRU de TOURS
[14] Centre Hospitalier Universitaire de Toulouse,UMR CNRS 7292 (GICC)
[15] Service d’Hépato-Gastro-Entérologie,Hôpital Trousseau—CHRU de TOURS
[16] Université François Rabelais,Institut Curie
[17] Service d’Anatomie et Cytologie Pathologiques—Tumorothèque,undefined
[18] PSL Research University,undefined
[19] INSERM U900,undefined
来源
British Journal of Cancer | 2018年 / 119卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Supplementary Table 1 and the Supplementary Figure legends were not included when this manuscript was first published. The files are now available here.
引用
收藏
页码:387 / 387
相关论文
共 50 条
  • [1] Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma
    Lievre, Astrid
    Ouine, Berengere
    Canet, Jim
    Cartier, Aurelie
    Amar, Yael
    Cacheux, Wulfran
    Mariani, Odette
    Guimbaud, Rosine
    Selves, Janick
    Lecomte, Thierry
    Guyetant, Serge
    Bieche, Ivan
    Berger, Frederique
    de Koning, Leanne
    BRITISH JOURNAL OF CANCER, 2017, 117 (12) : 1819 - 1827
  • [2] Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma
    Astrid Lièvre
    Bérèngere Ouine
    Jim Canet
    Aurélie Cartier
    Yael Amar
    Wulfran Cacheux
    Odette Mariani
    Rosine Guimbaud
    Janick Selves
    Thierry Lecomte
    Serge Guyetant
    Ivan Bieche
    Frédérique Berger
    Leanne de Koning
    British Journal of Cancer, 2017, 117 : 1819 - 1827
  • [3] Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma (vol 117, pg 1819, 2018)
    Lievre, Astrid
    Ouine, Berengere
    Canet, Jim
    Cartier, Aurelie
    Amar, Yael
    Cacheux, Wulfran
    Mariani, Odette
    Guimbaud, Rosine
    Selves, Janick
    Lecomte, Thierry
    Guyetant, Serge
    Bieche, Ivan
    Berger, Frederique
    de Koning, Leanne
    BRITISH JOURNAL OF CANCER, 2018, 119 (03) : 387 - 387
  • [4] Expression of pEGFR and pAKT as response-predictive biomarkers for RAS wild-type patients to anti-EGFR monoclonal antibodies in metastatic colorectal cancers
    Harle, A.
    Salleron, J.
    Perkins, G.
    Pilati, C.
    Blons, H.
    Laurent-Puig, P.
    Merlin, J. L.
    BRITISH JOURNAL OF CANCER, 2015, 113 (04) : 680 - 685
  • [5] Expression of pEGFR and pAKT as response-predictive biomarkers for RAS wild-type patients to anti-EGFR monoclonal antibodies in metastatic colorectal cancers
    A Harlé
    J Salleron
    G Perkins
    C Pilati
    H Blons
    P Laurent-Puig
    J L Merlin
    British Journal of Cancer, 2015, 113 : 680 - 685
  • [6] Biomarkers and anti-EGFR therapies for KRAS wild-type metastatic colorectal cancer
    Jose A. García-Sáenz
    Javier Sastre
    Eduardo Díaz-Rubio García
    Clinical and Translational Oncology, 2009, 11 : 737 - 747
  • [7] Biomarkers and anti-EGFR therapies for KRAS wild-type metastatic colorectal cancer
    Garcia-Saenz, Jose A.
    Sastre, Javier
    Diaz-Rubio Garcia, Eduardo
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (11): : 737 - 747
  • [8] Treatment of extended RAS/ BRAF wild-type metastatic colorectal cancer with anti-EGFR antibody combinations
    Voutsadakis, Ioannis A.
    PHARMACOGENOMICS, 2025,
  • [9] New predictive marker for anti-EGFR therapy in metastatic colorectal cancer with wild-type KRAS
    Kishiki, Tomokazu
    Masaki, Tadahiko
    Matsuoka, Hiroyoshi
    Kojima, Koichiro
    Asoh, Nobuyoshi
    Beniya, Ayumi
    Sakamoto, Yoshihiro
    Mori, Toshiyuki
    Abe, Nobutsugu
    CANCER SCIENCE, 2018, 109 : 1378 - 1378
  • [10] Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis
    Xiaona Lu
    Yuyao Li
    Yue Li
    Xuemei Zhang
    Jia Shi
    Hai Feng
    Zhuo Yu
    Yueqiu Gao
    BMC Cancer, 23